QA: Opiant Pharmaceuticals INC in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385508_2016_Opiant_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001385508, Opiant Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 467,360
1 IntangibleAssetsNetIncludingGoodwill 20,435
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 3,574,520
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,300,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,034,520
9 ResearchAndDevelopmentExpense 2,414,973
10 remainder_Expenses 0
11 remainder_Revenues 1,550,000
12 remainder_NetIncome -138,380
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 487,795
1 Liabilities 8,874,520
2 Expenses 8,449,493
3 Revenues 1,550,000
4 StockholdersEquity -8,386,725
5 NetIncome -7,037,873
6 ComprehensiveNetIncome -7,037,873
7 BaseVar 9,750,094
8 EconomicCapitalRatiobeforeLimitedLiability -5.41
9 EconomicCapitalRatio 0.136

Edgar->Model Mapping

Feature Distribution

Change over Time